MAPK/MAK/MRK overlapping kinase (32-40)

MAPK/MAK/MRK overlapping kinase (32-40) is a synthetic peptide fragment corresponding to residues 32 through 40 of the MAPK/MAK/MRK overlapping kinase protein. As a peptide compound, it represents a specific segment within the kinase's N-terminal region, offering a valuable tool for dissecting the structure-function relationships of this kinase family. The MAPK/MAK/MRK group encompasses serine/threonine kinases involved in diverse cellular signaling pathways, including cell cycle regulation, stress response, and differentiation. The (32-40) fragment is particularly relevant for researchers seeking to investigate the biochemical and biophysical properties of this kinase, as well as its interactions with regulatory proteins or substrates.

Epitope mapping: Synthetic peptides derived from kinase domains, such as the (32-40) fragment, are widely employed in epitope mapping studies. Researchers can use this peptide to identify and characterize antibody binding sites within the MAPK/MAK/MRK overlapping kinase, facilitating the development of highly specific polyclonal or monoclonal antibodies. Such antibodies are essential for probing kinase expression, localization, and post-translational modifications in diverse biological samples.

Protein-protein interaction studies: The (32-40) peptide fragment serves as a valuable probe for studying protein-protein interactions involving the N-terminal region of the MAPK/MAK/MRK kinase. By using this peptide in binding assays, researchers can elucidate interaction partners, determine binding affinities, and dissect the molecular determinants of association with regulatory proteins, adaptors, or substrates. These insights are critical for understanding the signaling mechanisms governed by this kinase family.

Kinase substrate specificity assessment: Short synthetic peptides that mimic specific regions of kinases are frequently used as substrates in in vitro kinase assays. The (32-40) segment can be incorporated into phosphorylation assays to evaluate the substrate specificity of the MAPK/MAK/MRK kinase or to test the activity of upstream kinases that may target this region. Such studies help delineate phosphorylation motifs and contribute to mapping the functional landscape of kinase signaling.

Peptide-based inhibitor screening: The defined sequence of the (32-40) peptide enables its use in screening for small molecule inhibitors or peptide antagonists that disrupt kinase interactions or activity. By employing this fragment in competitive binding or enzymatic assays, researchers can identify potential inhibitors that target the N-terminal domain, supporting early-stage drug discovery and mechanistic studies of kinase regulation in non-clinical research contexts.

Structural and biophysical characterization: The (32-40) peptide provides a tractable model for structural studies using techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), or mass spectrometry. Investigating the conformational properties and stability of this fragment can yield insights into the folding, flexibility, and dynamic behavior of the MAPK/MAK/MRK kinase's N-terminal domain. Such information is instrumental for rational design of modified peptides, understanding structure-function relationships, and guiding further biochemical experimentation.

1. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes